BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Xie H, Ying K, Xie B, Chen X, Yang B, Jin J, Wan J, Li T, Han W, Fang S, Wang H. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies. Biomaterials 2021;270:120705. [PMID: 33581609 DOI: 10.1016/j.biomaterials.2021.120705] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Ying K, Zhu Y, Wan J, Zhan C, Wang Y, Xie B, Xu P, Pan H, Wang H. Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis. Bioactive Materials 2023;20:449-462. [DOI: 10.1016/j.bioactmat.2022.06.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Sarwar U, Naeem M, Nurjis F, Karim S, Raza A. Ultrasound-mediated in vivo biodistribution of coumarin-labeled sorafenib-loaded liposome-based nanotheranostic system. Nanomedicine (Lond) 2023. [PMID: 36695214 DOI: 10.2217/nnm-2022-0137] [Reference Citation Analysis]
3 Zhang G, Han W, Zhao P, Wang Z, Li M, Sui X, Liu Y, Tian B, He Z, Fu Q. Programmed pH-responsive core-shell nanoparticles for precisely targeted therapy of ulcerative colitis. Nanoscale 2023. [PMID: 36625215 DOI: 10.1039/d2nr04968f] [Reference Citation Analysis]
4 Liu X, Xin Z, Wang K. Patient‐derived xenograft model in colorectal cancer basic and translational research. Anim Models and Exp Med 2022. [DOI: 10.1002/ame2.12299] [Reference Citation Analysis]
5 Zhang H, Wei S, Zhang Y, Pan A, Adu-Frimpong M, Sun C, Qi G. Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome. Drug Deliv 2022;29:2491-7. [PMID: 35912819 DOI: 10.1080/10717544.2022.2104406] [Reference Citation Analysis]
6 Chen X, Cui L, Xu J, Xian S, Meng F, Zhan C, Wang H. De novo engineering of both an omega-3 fatty acid-derived nanocarrier host and a prodrug guest to potentiate drug efficacy against colorectal malignancies. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121814] [Reference Citation Analysis]
7 Bian S, Dong H, Zhao L, Li Z, Chen J, Zhu X, Qiu N, Jia X, Song W, Li Z, Zheng S, Wang H, Song P. Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer. Adv Sci (Weinh) 2022;:e2201931. [PMID: 36026578 DOI: 10.1002/advs.202201931] [Reference Citation Analysis]
8 Meng Q, Zhong S, Gao Y, Cui X. Advances in polysaccharide-based nano/microcapsules for biomedical applications: A review. Int J Biol Macromol 2022;220:878-91. [PMID: 36007696 DOI: 10.1016/j.ijbiomac.2022.08.129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu Y, Sukumar UK, Jugniot N, Seetharam SM, Rengaramachandran A, Sadeghipour N, Mukherjee P, Krishnan A, Massoud TF, Paulmurugan R. Inhaled Gold Nano-star Carriers for Targeted Delivery of Triple Suicide Gene Therapy and Therapeutic MicroRNAs to Lung Metastases: Development and Validation in a Small Animal Model. Adv Ther (Weinh) 2022;5:2200018. [PMID: 36212523 DOI: 10.1002/adtp.202200018] [Reference Citation Analysis]
10 Nguyen A, Chao P, Ong CY, Rouhollahi E, Fayez NA, Lin L, Brown JI, Böttger R, Page B, Wong H, Li S. Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121735] [Reference Citation Analysis]
11 Almeida A, Castro F, Resende C, Lúcio M, Schwartz S Jr, Sarmento B. Oral delivery of camptothecin-loaded multifunctional chitosan-based micelles is effective in reduce colorectal cancer. J Control Release 2022:S0168-3659(22)00448-5. [PMID: 35905784 DOI: 10.1016/j.jconrel.2022.07.029] [Reference Citation Analysis]
12 Ren L, Xu P, Yao J, Wang Z, Shi K, Han W, Wang H. Targeting the Mitochondria with Pseudo-Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment. ACS Nano 2022. [PMID: 35820199 DOI: 10.1021/acsnano.1c08008] [Reference Citation Analysis]
13 Gao Y, Qiu W, Liang M, Ma X, Ye M, Xue P, Kang Y, Deng J, Xu Z. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy. Acta Biomater 2022:S1742-7061(22)00322-1. [PMID: 35640802 DOI: 10.1016/j.actbio.2022.05.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hao D, Wang Y, Yang J, Xie R, Jia L, Cheng J, Ma H, Tian J, Guo S, Liu T, Sui F, Zhao Y, Chen Y, Zhao Q. The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs. Front Pharmacol 2022;13:860492. [DOI: 10.3389/fphar.2022.860492] [Reference Citation Analysis]
15 Zhong W, Zhang X, Duan X, Liu H, Fang Y, Luo M, Fang Z, Miao C, Lin D, Wu J. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy. Acta Biomater 2022;144:67-80. [PMID: 35331940 DOI: 10.1016/j.actbio.2022.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ding K, Wang L, Zhu J, He D, Huang Y, Zhang W, Wang Z, Qin A, Hou J, Tang BZ. Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin Coated AIE Aggregates. ACS Nano 2022. [PMID: 35413177 DOI: 10.1021/acsnano.1c10770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
17 Wang H, Bai H, Wang J, Zhou X, Chen H, Wang L, Ren H, Liu Z, Zhuo W, Zhou Z, Tang J, Li Z, Wang J, Shen Y, Zhou T, Liu X. Nanoprodrug ratiometrically integrating autophagy inhibitor and genotoxic agent for treatment of triple-negative breast cancer. Biomaterials 2022;283:121458. [DOI: 10.1016/j.biomaterials.2022.121458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Li T, Shi W, Yao J, Hu J, Sun Q, Meng J, Wan J, Song H, Wang H. Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy. Biomater Res 2022;26. [DOI: 10.1186/s40824-022-00249-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shi L, Wu X, Li T, Wu Y, Song L, Zhang W, Yin L, Wu Y, Han W, Yang Y. An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety. Nanoscale Adv . [DOI: 10.1039/d1na00838b] [Reference Citation Analysis]
20 Xu B, Yan M, Zhou F, Cai D, Guo W, Jia X, Liu R, Ma T, Li T, Gao F, Wang P, Lei H. Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin-Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery. Int J Nanomedicine 2021;16:7959-74. [PMID: 34887660 DOI: 10.2147/IJN.S331060] [Reference Citation Analysis]
21 He W, Du Y, Wang T, Wang J, Cheng L, Li X. Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation. Int J Pharm 2021;606:120856. [PMID: 34229071 DOI: 10.1016/j.ijpharm.2021.120856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Nguyen A, Böttger R, Li SD. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials. Biomaterials 2021;275:120955. [PMID: 34130143 DOI: 10.1016/j.biomaterials.2021.120955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]